{"id":"bpo","safety":{"commonSideEffects":[{"rate":"10–25%","effect":"Skin irritation, erythema, and dryness"},{"rate":"5–15%","effect":"Peeling and desquamation"},{"rate":"1–3%","effect":"Contact dermatitis or allergic reaction"},{"rate":"null","effect":"Bleaching of hair or fabrics"}]},"_chembl":null,"_dailymed":{"setId":"eb55cc26-cf47-4e9e-b7a8-23ef82aecce2","title":"PCA SKIN BPO CLEANSER (BENZOYL PEROXIDE) GEL [CP SKIN HEALTH GROUP, INC.]"},"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Benzoyl peroxide is an antimicrobial and keratolytic agent that generates reactive oxygen species to eliminate Cutibacterium acnes (formerly Propionibacterium acnes). It also has mild comedolytic properties that help unclog pores and reduce inflammatory lesions. The drug does not induce bacterial resistance, making it a durable first-line treatment for acne.","oneSentence":"BPO (benzoyl peroxide) kills acne-causing bacteria and reduces sebum production while promoting skin cell turnover.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:39:37.971Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Acne vulgaris (mild to moderate)"},{"name":"Acne rosacea (adjunctive)"}]},"trialDetails":[{"nctId":"NCT07334730","phase":"","title":"The Effects of Holmium Laser Enucleation and Thulium Laser Enucleation on Continence, Urethral Stricture, and Sexual Function in Benign Prostatic Hyperplasia","status":"NOT_YET_RECRUITING","sponsor":"TC Erciyes University","startDate":"2026-02-01","conditions":"Benign Prostate Obstruction (BPO)","enrollment":200},{"nctId":"NCT05582434","phase":"EARLY_PHASE1","title":"Experience With Topical Acne Treatment","status":"ACTIVE_NOT_RECRUITING","sponsor":"Wake Forest University Health Sciences","startDate":"2024-02-15","conditions":"Acne","enrollment":72},{"nctId":"NCT07283484","phase":"NA","title":"Early Versus Delayed Trial Without Catheter in Men With Acute Urinary Retention.","status":"RECRUITING","sponsor":"Liselot Ribbert","startDate":"2025-08-21","conditions":"Acute Urinary Retention, Benign Prostate Obstruction, Benign Prostate Hyperplasia","enrollment":478},{"nctId":"NCT05495633","phase":"","title":"SteamOne - Prospective Database for Rezum Water Vapor Therapy of the Prostate","status":"RECRUITING","sponsor":"University Hospital, Basel, Switzerland","startDate":"2022-12-16","conditions":"Benign Prostate Obstruction (BPO)","enrollment":1000},{"nctId":"NCT04892706","phase":"PHASE2","title":"Study to Compare the Safety and Efficacy of IDP-126 Gel to Epiduo® Forte Gel and Vehicle Gel","status":"COMPLETED","sponsor":"Bausch Health Americas, Inc.","startDate":"2021-06-11","conditions":"Acne Vulgaris","enrollment":686},{"nctId":"NCT07159165","phase":"","title":"Registry of MIUS for Benign Prostatic Obstruction","status":"ENROLLING_BY_INVITATION","sponsor":"Ondokuz Mayıs University","startDate":"2025-07-01","conditions":"Benign Prostatic Hyperplasia With Lower Urinary Tract Symptoms","enrollment":10000},{"nctId":"NCT07047599","phase":"","title":"Uroflowmetry and IPSS Factors Influencing Surgical Decision","status":"NOT_YET_RECRUITING","sponsor":"Marmara University","startDate":"2025-09-15","conditions":"Lower Urinary Tract Symptom, Benign Prostate Obstruction (BPO), Voiding Dysfunction","enrollment":100},{"nctId":"NCT07055425","phase":"","title":"Association Between Qmax/eGFR Ratio and LUTS Severity in Men Over 40","status":"NOT_YET_RECRUITING","sponsor":"Marmara University","startDate":"2025-09-01","conditions":"Lower Urinary Tract Symptom, Voiding Dysfunction, Male Urological Health","enrollment":100},{"nctId":"NCT06989515","phase":"","title":"Clinical Outcomes and Ejaculatory Function in BPO Patients Treated With Silodosin","status":"NOT_YET_RECRUITING","sponsor":"Marmara University","startDate":"2025-06-15","conditions":"Benign Prostate Obstruction (BPO), Lower Urinary Tract Symptom, Ejaculatory Dysfunction","enrollment":100},{"nctId":"NCT06564415","phase":"","title":"European Registry for Transperineal Laser Ablation of Prostate (TPLA) for Lower Urinary Tract Symptoms","status":"RECRUITING","sponsor":"University of Florence","startDate":"2024-01-11","conditions":"Benign Prostatic Hyperplasia, Prostatic Diseases","enrollment":2500},{"nctId":"NCT05676411","phase":"PHASE4","title":"Benzoyl Peroxide and Electrocautery Skin Incision to Eradicate Cutibacterium Acnes","status":"WITHDRAWN","sponsor":"University of Missouri-Columbia","startDate":"2024-06-01","conditions":"Prosthetic-joint Infection","enrollment":""},{"nctId":"NCT05536882","phase":"PHASE3","title":"MC RCT - BPO vs Adapalene","status":"WITHDRAWN","sponsor":"University of Oklahoma","startDate":"2022-05-18","conditions":"Molluscum Contagiosum","enrollment":""},{"nctId":"NCT04548349","phase":"PHASE4","title":"Profiling the Skin Microbiome in Response to Altreno in Acne Patients","status":"COMPLETED","sponsor":"Beth Israel Deaconess Medical Center","startDate":"2021-04-23","conditions":"Acne, Healthy","enrollment":25},{"nctId":"NCT04112407","phase":"NA","title":"The Effect of Pretreatment for Propionibacterium Acnes on Surgical Site Burden in Shoulder Arthroplasty","status":"COMPLETED","sponsor":"Albany Medical College","startDate":"2019-01-10","conditions":"Shoulder Arthroplasty","enrollment":120},{"nctId":"NCT03076320","phase":"PHASE1, PHASE2","title":"Pirfenidone Plus M-DDO Gel in Moderate and Severe Acne","status":"COMPLETED","sponsor":"University of Guadalajara","startDate":"2017-03-27","conditions":"Acne Vulgaris Superficial Mixed Comedonal and Inflammatory","enrollment":82},{"nctId":"NCT04437108","phase":"NA","title":"Efficacy of Li-SWT on Persistent Storage Symptoms After Transurethral Surgery for BPO","status":"COMPLETED","sponsor":"Mansoura University","startDate":"2020-07-04","conditions":"Overactive Bladder, Urinary Incontinence, Urge, Urgency-frequency Syndrome","enrollment":132},{"nctId":"NCT05675501","phase":"PHASE1","title":"Evaluation of Topical Encapsulated Benzoyl Peroxide on the Skin Microbiome and Skin Biophysical Properties","status":"COMPLETED","sponsor":"Sol-Gel Technologies, Ltd.","startDate":"2020-06-10","conditions":"Papulopustular Rosacea","enrollment":31},{"nctId":"NCT04781049","phase":"NA","title":"Transperineal Laser Ablation vs Transurethral Resection for Benign Prostatic Obstruction: A Randomized Clinical Trial","status":"COMPLETED","sponsor":"San Carlo di Nancy Hospital","startDate":"2021-01-01","conditions":"Prostate Hyperplasia, Benign Prostatic Hyperplasia, Benign Prostatic Hypertrophy","enrollment":51},{"nctId":"NCT03849885","phase":"PHASE4","title":"Cutibacterium Dermal Colonization: Implications for Total Hip Arthroplasty","status":"UNKNOWN","sponsor":"Colorado Joint Replacement","startDate":"2019-02-02","conditions":"Degenerative Osteoarthritis","enrollment":496},{"nctId":"NCT02735421","phase":"PHASE4","title":"Adapalene 0.3% - Benzoyl Peroxide 2.5% Gel and Risk of Formation of Atrophic Acne Scars","status":"COMPLETED","sponsor":"Galderma R&D","startDate":"2016-05-13","conditions":"Acne Vulgaris, Atrophic Acne Scars","enrollment":67},{"nctId":"NCT01951417","phase":"PHASE4","title":"Adapalene BPO Gel Pump, Moisturizer SPF 30 and Foam Wash in Patients With Mild to Moderate Acne Vulgaris","status":"COMPLETED","sponsor":"Galderma R&D","startDate":"2013-10","conditions":"Acne","enrollment":81},{"nctId":"NCT01209949","phase":"PHASE4","title":"Assessment of Subjects' Efficacy and Experiences Using Adapalene BPO Gel in the Treatment of Acne Vulgaris","status":"COMPLETED","sponsor":"Galderma R&D","startDate":"2010-10","conditions":"Acne Vulgaris","enrollment":30},{"nctId":"NCT03653117","phase":"NA","title":"Transperineal Laser Ablation for Treatment of Benign Prostatic Obstruction","status":"COMPLETED","sponsor":"Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)","startDate":"2018-10-18","conditions":"Prostatic Hyperplasia, Benign","enrollment":20},{"nctId":"NCT04300010","phase":"PHASE4","title":"Blue Light Therapy of C. Acnes","status":"COMPLETED","sponsor":"University of Wisconsin, Madison","startDate":"2020-10-05","conditions":"Acne","enrollment":60},{"nctId":"NCT04021524","phase":"PHASE4","title":"BPO vs Hibiclens Soap for Surgical Preparation","status":"COMPLETED","sponsor":"University of Washington","startDate":"2018-09-10","conditions":"Propionibacterium Acnes","enrollment":50},{"nctId":"NCT03761810","phase":"PHASE3","title":"A Study of S6G5T3 in the Treatment of Acne Vulgaris","status":"COMPLETED","sponsor":"Sol-Gel Technologies, Ltd.","startDate":"2018-12-14","conditions":"Acne Vulgaris","enrollment":434},{"nctId":"NCT03761784","phase":"PHASE3","title":"A Study of S6G5T-3 in the Treatment of Acne Vulgaris","status":"COMPLETED","sponsor":"Sol-Gel Technologies, Ltd.","startDate":"2018-12-21","conditions":"Acne Vulgaris","enrollment":424},{"nctId":"NCT03564119","phase":"PHASE3","title":"A Study of S5G4T-1 in the Treatment of Papularpustular Rosacea","status":"COMPLETED","sponsor":"Sol-Gel Technologies, Ltd.","startDate":"2018-06-21","conditions":"Papulopustular Rosacea","enrollment":372},{"nctId":"NCT03564145","phase":"PHASE3","title":"A Long-Term Safety Study of S5G4T-1 in the Treatment of Papulopustular Rosacea","status":"TERMINATED","sponsor":"Sol-Gel Technologies, Ltd.","startDate":"2018-09-12","conditions":"Papulopustular Rosacea","enrollment":547},{"nctId":"NCT03448939","phase":"PHASE3","title":"A Study of S5G4T-1 in the Treatment of Papulopustular Rosacea","status":"COMPLETED","sponsor":"Sol-Gel Technologies, Ltd.","startDate":"2018-06-18","conditions":"Papulopustular Rosacea","enrollment":361},{"nctId":"NCT00687908","phase":"PHASE3","title":"Adapalene-Benzoy Peroxide (BPO) Gel in the Treatment of Acne Vulgaris as a 6-month Maintenance","status":"COMPLETED","sponsor":"Galderma R&D","startDate":"2008-11","conditions":"Acne","enrollment":243},{"nctId":"NCT01188538","phase":"PHASE4","title":"Anti Propionibacterium(P.) Acnes Activity of Epiduo® Gel Compared to Benzoyl Peroxide (BPO) 2.5% Gel","status":"COMPLETED","sponsor":"Galderma R&D","startDate":"2010-03","conditions":"Acne Vulgaris","enrollment":40},{"nctId":"NCT00688064","phase":"PHASE3","title":"Adapalene-BPO Gel Associated With Doxycycline Hyclate 100 mg in the Treatment of Severe Acne Vulgaris","status":"COMPLETED","sponsor":"Galderma R&D","startDate":"2008-08","conditions":"Severe Acne Vulgaris","enrollment":459},{"nctId":"NCT01014689","phase":"PHASE3","title":"Comparison of Epiduo Associated With Lymecycline Versus Epiduo Vehicle Associated With Lymecycline in Acne Vulgaris","status":"COMPLETED","sponsor":"Galderma R&D","startDate":"2009-08","conditions":"Acne Vulgaris","enrollment":378},{"nctId":"NCT00883233","phase":"PHASE3","title":"Comparison of Four Different Regimens of Adapalene 0.1% / Benzoyl Peroxide 2.5% Gel in Acne Vulgaris","status":"COMPLETED","sponsor":"Galderma R&D","startDate":"2009-04","conditions":"Acne","enrollment":123},{"nctId":"NCT02932267","phase":"PHASE3","title":"Subject Reported Outcomes With Use of Adapalene 0.3% - Benzoyl Peroxide (BPO) 2.5% in Dark Skin Acne","status":"COMPLETED","sponsor":"Galderma R&D","startDate":"2017-02-02","conditions":"Acne Vulgaris","enrollment":50},{"nctId":"NCT00441415","phase":"PHASE3","title":"Efficacy and Safety of Fixed Combination Adapalene 0.1% / Benzoyl Peroxide 2.5% Gel in the Treatment of Acne Vulgaris","status":"COMPLETED","sponsor":"Galderma R&D","startDate":"2007-02","conditions":"Acne Vulgaris","enrollment":272},{"nctId":"NCT02757963","phase":"PHASE4","title":"Benign Prostatic Hyperplasia (BPH) Screening Tool Case Finding Study in Subjects >=50 Years","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2016-05-12","conditions":"Prostatic Hyperplasia","enrollment":1679},{"nctId":"NCT03709654","phase":"PHASE1","title":"A Study of the Safety, Engraftment, and Action of Multi-Dosed NB01 in Adults With Moderate Acne","status":"COMPLETED","sponsor":"Naked Biome, Inc.","startDate":"2018-11-01","conditions":"Acne Vulgaris","enrollment":36},{"nctId":"NCT03239951","phase":"NA","title":"Study to Assess the Efficacy, Safety and Tolerability of (iTind)","status":"TERMINATED","sponsor":"Medi-Tate Ltd.","startDate":"2018-02-27","conditions":"BPH","enrollment":5},{"nctId":"NCT02616614","phase":"PHASE3","title":"Double-blind Placebo-controlled Trial of Generic Clindamycin/Benzoyl Peroxide Gel Versus Onexton Gel in Acne Vulgaris","status":"COMPLETED","sponsor":"Actavis Inc.","startDate":"2015-05","conditions":"Acne Vulgaris","enrollment":862},{"nctId":"NCT01781117","phase":"NA","title":"Prognostic Value of the Urinary Nerve Growth Factor in the Patients With Benign Prostatic Hyperplasia","status":"COMPLETED","sponsor":"KYU-SUNG LEE","startDate":"2013-02","conditions":"Benign Prostatic Hypertrophy With Outflow Obstruction, Overactive Detrusor","enrollment":184},{"nctId":"NCT00922506","phase":"PHASE4","title":"Combination Treatment With Doxazosin Plus TolterodineSR 2 mg Versus 4mg in Men With an Overactive Bladder (OAB) and Benign Prostatic Hyperplasia (BPH)","status":"COMPLETED","sponsor":"Samsung Medical Center","startDate":"2009-05","conditions":"Overactive Bladder, Benign Prostatic Hyperplasia","enrollment":83},{"nctId":"NCT03318991","phase":"NA","title":"Clinical Outcomes of Laser Prostatectomy","status":"UNKNOWN","sponsor":"National Taiwan University","startDate":"2017-10-01","conditions":"Prostatic Hypertrophy","enrollment":100},{"nctId":"NCT02578043","phase":"PHASE1","title":"A Study Comparing Clindamycin and Benzoyl Peroxide Gel 1.2%/3.75% to Onexton™ Gel in the Treatment of Acne Vulgaris","status":"COMPLETED","sponsor":"Sun Pharmaceutical Industries, Inc.","startDate":"2015-04","conditions":"Acne Vulgaris","enrollment":844},{"nctId":"NCT01445301","phase":"PHASE3","title":"Study STF115287, a Clinical Confirmation Study of GSK2585823 in the Treatment of Acne Vulgaris in Japanese Subjects","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2011-09-27","conditions":"Acne Vulgaris","enrollment":800},{"nctId":"NCT02698436","phase":"NA","title":"A Study to Evaluate the Effectiveness and Tolerance of Two Acne Treatments on Subjects With Mild to Moderate Acne.","status":"COMPLETED","sponsor":"Johnson & Johnson Consumer and Personal Products Worldwide","startDate":"2016-03-31","conditions":"Acne Vulgaris","enrollment":103},{"nctId":"NCT01706263","phase":"PHASE4","title":"U0289-402: An Open Label, 8 Week Study to Evaluate the Efficacy and Tolerability of MAXCLARITY II in Subjects With Acne","status":"COMPLETED","sponsor":"Stiefel, a GSK Company","startDate":"2009-08-01","conditions":"Acne Vulgaris","enrollment":28},{"nctId":"NCT02058628","phase":"PHASE4","title":"Comparison of the Efficacy and Safety of Clindamycin + Benzoyl Peroxide Formulation With Azelaic Acid Formulation in the Treatment of Acne Vulgaris","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2014-02-21","conditions":"Acne Vulgaris","enrollment":222},{"nctId":"NCT01706250","phase":"PHASE4","title":"U0289-401: Eight Week, Split-face, Study to Determine and Compare the Efficacy and Tolerability of MAXCLARITY™ II to PROACTIV™","status":"COMPLETED","sponsor":"Stiefel, a GSK Company","startDate":"2009-09-01","conditions":"Acne Vulgaris","enrollment":20},{"nctId":"NCT00757523","phase":"PHASE4","title":"Evaluation of the Effectiveness, Safety, and Tolerability of Duac Akne Gel and Epiduo Gel in the Treatment of Facial Acne Vulgaris","status":"COMPLETED","sponsor":"Stiefel, a GSK Company","startDate":"2008-09-10","conditions":"Acne Vulgaris","enrollment":382},{"nctId":"NCT01132443","phase":"PHASE1","title":"W0261-101: A Phase 1, Single Center, Randomized, Open-Label Study to Evaluate the Bioavailability of Clindamycin From Clindamycin 1%-Benzoyl Peroxide 3% Gel, Topical Gel (Clindamycin 1%- Benzoyl Peroxide 5%), and Once Daily Gel (Clindamycin 1%-Benzoyl Peroxide 5%) in Subjects With Acne","status":"COMPLETED","sponsor":"Stiefel, a GSK Company","startDate":"2010-05-06","conditions":"Acne Vulgaris","enrollment":72},{"nctId":"NCT00964366","phase":"PHASE4","title":"Study to Determine and Compare the Tolerance and Irritation Potential of Topical Acne Medications","status":"COMPLETED","sponsor":"Stiefel, a GSK Company","startDate":"2009-07","conditions":"Acne Vulgaris","enrollment":53},{"nctId":"NCT00837213","phase":"PHASE4","title":"Comparative Efficacy and Safety of Benzoyl Peroxide Used in Combination With Clindamycin vs. Benzoyl Peroxide Used in Combination With Clindamycin and Doxycycline in the Treatment of Moderate Acne","status":"COMPLETED","sponsor":"Stiefel, a GSK Company","startDate":"2007-08","conditions":"Acne","enrollment":33},{"nctId":"NCT00891982","phase":"PHASE3","title":"A Clinical Study to Evaluate the Tolerability of a Topical Antibiotic and Retinoid Used in a Combined Regimen With a BPO Wash","status":"COMPLETED","sponsor":"Stiefel, a GSK Company","startDate":"2009-04-01","conditions":"Acne Vulgaris","enrollment":60},{"nctId":"NCT02524665","phase":"PHASE4","title":"8 Week Study to Evaluate and Compare the Efficacy and Tolerability of MAXCLARITY II and MURAD To Treat Acne","status":"COMPLETED","sponsor":"Stiefel, a GSK Company","startDate":"2009-09","conditions":"Acne Vulgaris","enrollment":20},{"nctId":"NCT01015638","phase":"PHASE4","title":"Compare the Tolerance of Clindamycin 1% /Benzoyl Peroxide (BPO) 5% Gel to Clindamycin 1.2%/ BPO 2.5% Topical Medications","status":"COMPLETED","sponsor":"Stiefel, a GSK Company","startDate":"2009-08","conditions":"Acne Vulgaris","enrollment":36},{"nctId":"NCT01910064","phase":"PHASE3","title":"A Long Term Study of GK530G in Subjects With Acne Vulgaris","status":"COMPLETED","sponsor":"Galderma R&D","startDate":"2013-05","conditions":"Acne Vulgaris","enrollment":436},{"nctId":"NCT01846793","phase":"PHASE3","title":"Phase 3 Evaluation of Re-Injection of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH)(NX02-0022)","status":"COMPLETED","sponsor":"Nymox Corporation","startDate":"2013-04","conditions":"Benign Prostatic Hyperplasia, BPH, Lower Urinary Tract Symptoms (LUTS)","enrollment":160},{"nctId":"NCT00776919","phase":"PHASE3","title":"Trial of Clindamycin / Benzoyl Peroxide Gel in Subjects With Acne","status":"COMPLETED","sponsor":"Stiefel, a GSK Company","startDate":"2008-10","conditions":"Acne Vulgaris","enrollment":1315},{"nctId":"NCT00926367","phase":"PHASE4","title":"Two-week Study to Compare the Tolerance and Irritation Potential of Two Combination Topical Gel Acne Medications","status":"COMPLETED","sponsor":"Stiefel, a GSK Company","startDate":"2009-05","conditions":"Acne Vulgaris","enrollment":52},{"nctId":"NCT02192632","phase":"NA","title":"Dermatologists' Educational Demonstration for Epiduo Application","status":"COMPLETED","sponsor":"Seoul National University Hospital","startDate":"2014-01","conditions":"Facial Acne, Local Adverse Effects","enrollment":85},{"nctId":"NCT01400932","phase":"PHASE3","title":"Study STF115288, a Clinical Confirmation Study of GI148512 in the Treatment of Acne Vulgaris in Japanese Subjects","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2011-07","conditions":"Acne Vulgaris","enrollment":360},{"nctId":"NCT01438775","phase":"PHASE3","title":"Phase 3 Evaluation of Re-Injection of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH)","status":"COMPLETED","sponsor":"Nymox Corporation","startDate":"2011-09","conditions":"Benign Prostatic Hyperplasia","enrollment":192},{"nctId":"NCT01149330","phase":"PHASE4","title":"Evaluation of Efficacy and Safety of Adapalene 0.1%/Benzoyl Peroxide 2.5% Gel in the Treatment of Acne Vulgaris","status":"COMPLETED","sponsor":"Galderma Brasil Ltda.","startDate":"2010-07","conditions":"Acne Vulgaris","enrollment":75},{"nctId":"NCT00617266","phase":"PHASE3","title":"Tobacco Control Among Business Process Outsourcing (BPO) Employees","status":"UNKNOWN","sponsor":"Tata Memorial Hospital","startDate":"2007-08","conditions":"Tobacco Use Cessation","enrollment":800}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":1449,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"BPO","genericName":"BPO","companyName":"Galderma R&D","companyId":"galderma-r-d","modality":"Small molecule","firstApprovalDate":"","aiSummary":"BPO (benzoyl peroxide) kills acne-causing bacteria and reduces sebum production while promoting skin cell turnover. Used for Acne vulgaris (mild to moderate), Acne rosacea (adjunctive).","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}